220 related articles for article (PubMed ID: 38737334)
1. A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid 'xenoautoantigen' Neu5Gc in humans and the need for a standardised approach to quantification.
Hutton E; Scott E; Robson CN; Signoret N; Fascione MA
Front Mol Biosci; 2024; 11():1390711. PubMed ID: 38737334
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
Samraj AN; Bertrand KA; Luben R; Khedri Z; Yu H; Nguyen D; Gregg CJ; Diaz SL; Sawyer S; Chen X; Eliassen H; Padler-Karavani V; Wu K; Khaw KT; Willett W; Varki A
PLoS One; 2018; 13(6):e0197464. PubMed ID: 29912879
[TBL] [Abstract][Full Text] [Related]
3. From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.
Dhar C; Sasmal A; Varki A
Front Immunol; 2019; 10():807. PubMed ID: 31057542
[TBL] [Abstract][Full Text] [Related]
4. Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products.
Diaz SL; Padler-Karavani V; Ghaderi D; Hurtado-Ziola N; Yu H; Chen X; Brinkman-Van der Linden EC; Varki A; Varki NM
PLoS One; 2009; 4(1):e4241. PubMed ID: 19156207
[TBL] [Abstract][Full Text] [Related]
5. Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.
Taylor RE; Gregg CJ; Padler-Karavani V; Ghaderi D; Yu H; Huang S; Sorensen RU; Chen X; Inostroza J; Nizet V; Varki A
J Exp Med; 2010 Aug; 207(8):1637-46. PubMed ID: 20624889
[TBL] [Abstract][Full Text] [Related]
6. Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans-An Evolutionary Perspective.
Altman MO; Gagneux P
Front Immunol; 2019; 10():789. PubMed ID: 31134048
[TBL] [Abstract][Full Text] [Related]
7. Involvement of a non-human sialic Acid in human cancer.
Samraj AN; Läubli H; Varki N; Varki A
Front Oncol; 2014; 4():33. PubMed ID: 24600589
[TBL] [Abstract][Full Text] [Related]
8. Are there specific antibodies against Neu5Gc epitopes in the blood of healthy individuals?
Obukhova P; Tsygankova S; Chinarev A; Shilova N; Nokel A; Kosma P; Bovin N
Glycobiology; 2020 May; 30(6):395-406. PubMed ID: 31897477
[TBL] [Abstract][Full Text] [Related]
9. Human species-specific loss of CMP-
Kawanishi K; Dhar C; Do R; Varki N; Gordts PLSM; Varki A
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16036-16045. PubMed ID: 31332008
[TBL] [Abstract][Full Text] [Related]
10. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
Padler-Karavani V; Hurtado-Ziola N; Pu M; Yu H; Huang S; Muthana S; Chokhawala HA; Cao H; Secrest P; Friedmann-Morvinski D; Singer O; Ghaderi D; Verma IM; Liu YT; Messer K; Chen X; Varki A; Schwab R
Cancer Res; 2011 May; 71(9):3352-63. PubMed ID: 21505105
[TBL] [Abstract][Full Text] [Related]
11. Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.
Yehuda S; Padler-Karavani V
Front Immunol; 2020; 11():21. PubMed ID: 32038661
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.
Banda K; Gregg CJ; Chow R; Varki NM; Varki A
J Biol Chem; 2012 Aug; 287(34):28852-64. PubMed ID: 22692204
[TBL] [Abstract][Full Text] [Related]
13. An Overview of the Importance and Value of Porcine Species in Sialic Acid Research.
Ogun OJ; Thaller G; Becker D
Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741423
[TBL] [Abstract][Full Text] [Related]
14. Current views on N-glycolylneuraminic acid in therapeutic recombinant proteins.
Mastrangeli R; Audino MC; Palinsky W; Broly H; Bierau H
Trends Pharmacol Sci; 2021 Nov; 42(11):943-956. PubMed ID: 34544608
[TBL] [Abstract][Full Text] [Related]
15. Method establishment for discerned immunogenicity assessment of a recombinant glycoprotein containing nonhuman sialic acid Neu5Gc residues.
Montjovent MO; Zou L; Faust H; Abdolzade-Bavil A; Liu PM; Struwe P
Bioanalysis; 2017 Sep; 9(18):1385-1393. PubMed ID: 28956633
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium.
Pham T; Gregg CJ; Karp F; Chow R; Padler-Karavani V; Cao H; Chen X; Witztum JL; Varki NM; Varki A
Blood; 2009 Dec; 114(25):5225-35. PubMed ID: 19828701
[TBL] [Abstract][Full Text] [Related]
17. Specific Detection of Neu5Gc in Animal Tissues by Immunohistochemistry.
Paul A; Bachar Abramovitch S; Padler-Karavani V
Methods Mol Biol; 2020; 2110():59-72. PubMed ID: 32002901
[TBL] [Abstract][Full Text] [Related]
18. Presentation Mode of Glycans Affect Recognition of Human Serum anti-Neu5Gc IgG Antibodies.
Bashir S; Leviatan Ben Arye S; Reuven EM; Yu H; Costa C; Galiñanes M; Bottio T; Chen X; Padler-Karavani V
Bioconjug Chem; 2019 Jan; 30(1):161-168. PubMed ID: 30500162
[TBL] [Abstract][Full Text] [Related]
19. Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.
Ghaderi D; Taylor RE; Padler-Karavani V; Diaz S; Varki A
Nat Biotechnol; 2010 Aug; 28(8):863-7. PubMed ID: 20657583
[TBL] [Abstract][Full Text] [Related]
20. The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation.
Tector AJ; Mosser M; Tector M; Bach JM
Front Immunol; 2020; 11():622. PubMed ID: 32351506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
